The 21ST CENTURY BIOSIMILARS brand, founded in 2014 (Germany), from 2 sister brands and 2214 competing brands. The 21ST CENTURY BIOSIMILARS brand is owned by Formycon, a company listed in Francfort. The International Securities Identification Number (ISIN) of Formycon is DE000A1EWVY8. 21ST CENTURY BIOSIMILARS belongs to the Biotechnology business sector.

21ST CENTURY BIOSIMILARS is a brand of Formycon (FYB) Share price

International deposit : 2014 Business sector Biotechnology

Share price and profitability of the share Formycon (21ST CENTURY BIOSIMILARS)

Buy Formycon share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested EUR 39.50

Portfolio valuation
Formycon (21ST CENTURY BIOSIMILARS) over 5 years* EUR 43.91

Stock market history Formycon (21ST CENTURY BIOSIMILARS)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
Formycon

See more brands of Formycon

Rival brands
21ST CENTURY BIOSIMILARS

NOTABLE LABS
NOTABLE LABS
Roivant
Roivant
Valerio Therapeutics
Valerio Therapeutics
INVERSAGO
INVERSAGO
Terns Pharma
Terns Pharma
Vaxcyte
Vaxcyte
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands that generate Pricing Power and therefore stock market performance
Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS